RT Journal Article
SR Electronic
T1 WiFi mobility models for COVID-19 enable less burdensome and more localized interventions for university campuses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.16.21253662
DO 10.1101/2021.03.16.21253662
A1 Vedant Das Swain
A1 Jiajia Xie
A1 Maanit Madan
A1 Sonia Sargolzaei
A1 James Cai
A1 Munmun De Choudhury
A1 Gregory D. Abowd
A1 Lauren N. Steimle
A1 B. Aditya Prakash
YR 2021
UL http://medrxiv.org/content/early/2021/03/24/2021.03.16.21253662.abstract
AB Infectious diseases, like COVID-19, pose serious challenges to university campuses, and they typically adopt closure as a non-pharmaceutical intervention to control spread early and ensure a gradual return to normalcy. These policies, like remote instruction (RI), reduce potential contact but also have broad side-effects on campus by hampering local economy, students’ learning outcomes, and community wellbeing. In this paper, we demonstrate that university policymakers can mitigate these tradeoffs by leveraging anonymized data from their WiFi infrastructure to learn community mobility (WiMob) and in turn explore more granular policies like localized closures (LC). WiMob can construct contact networks that capture behavior in a variety of spaces, highlighting new potential transmission pathways and temporal variation in contact behavior. Additionally, WiMob enables us to design LC policies that close super-spreader locations on campus. On simulating disease spread with contact networks from WiMob, we find that LC maintains the same reduction in cumulative infections as RI while showing greater reduction in peak infections and internal transmission. Moreover, LC reduces campus burden by closing fewer locations, forcing fewer students into completely online schedules, and requiring no additional isolation. WiMob can empower universities to conceive and assess a variety of closure policies to prevent future outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper is based on work partially supported by the NSF (Expeditions CCF-1918770, CAREER IIS-2028586, RAPID IIS-2027862, RAPID IIS-2027689, Medium IIS-1955883, NRT DGE-1545362, CCF-2115126), CDC MInD program, ORNL, and Semiconductor Research Corporation (in collaboration with Intel Labs). Some research personnel were supported by internal seed funding from the Georgia Institute of Technology and Georgia Tech Research Institute. Other computing resources were provided by the Office of Information Technology at Georgia Tech.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Central Institutional Review Board (IRB), Georgia Institute of TechnologyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified version of this data can be requested by interested parties through appropriate data use agreements